wintrymix.png
Monday January 17th, 2022 1:26AM
12:00AM ( 1 hour ago ) News Alert

Biden picks former FDA chief Califf to again lead the agency

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — President Joe Biden on Friday is tapping former Food and Drug Administration commissioner Robert Califf to again lead the powerful regulatory agency, according to a person familiar with the decision.

Califf's nomination comes after months of the concern that the agency near the center of the government’s COVID-19 response has lacked a permanent leader. More than a half-dozen names were floated for the job before the White House settled on Califf.

Biden is to make the formal announcement later Friday, said the person familiar, who spoke on the condition of anonymity to preview the announcement.

A cardiologist and clinical trial specialist, Califf, 70, served as FDA commissioner for the last 11 months of President Barack Obama's second term. Before that, he spent one year as the agency's No. 2 official after more than 35 years as a prominent researcher at Duke University, where he helped design studies for many of the world's biggest drugmakers.

Since leaving the government, he has worked as a policy adviser to tech giant Google, in addition to his ongoing work at the Duke Clinical Research Institute.

If confirmed by the Senate, Califf would oversee decisions on COVID-19 vaccines along with a raft of other knotty issues, including the regulation of electronic cigarettes and effectiveness standards for prescription drugs. He would be the first FDA commissioner since the 1940s to return for a second stint leading the agency.

“Rob is a relatively safe choice because he is known in Washington and is widely respected,” said Wayne Pines, a former FDA associate commissioner who has helped several commissioners through the confirmation process. “He will have broad support from FDA stakeholders.”

The FDA regulates the vaccines, drugs and tests used to combat COVID-19. That’s on top of its normal duties regulating a swath of consumers goods and medicines, including prescription drugs, medical devices, tobacco products, cosmetics and most foods.

Dr. Janet Woodcock, the agency’s longtime drug director, has been serving as acting commissioner since January. For months she was expected to be tapped for the permanent post, but her nomination ran into pushback from key Democratic lawmakers, including Sen. Joe Manchin of West Virginia, over the handling of opioid prescription painkillers during her 30-plus years at the agency.

The White House faced a legal deadline of mid-November to nominate a permanent commissioner or name another acting commissioner.

Califf arrived at the FDA in 2015 determined to modernize how the agency reviewed drug and device study data. But his brief time as commissioner was dominated by unrelated pharmaceutical controversies, including the surging epidemic of opioid addiction and overdoses.

He was among the first FDA officials to publicly acknowledge missteps in the agency’s oversight of painkillers like OxyContin, which is widely blamed for sparking the ongoing opioid epidemic, now driven by heroin and fentanyl.

“If addiction to opioids and misuse of opioids is an enemy then we at the FDA — like every other part of society — underestimated the tenacity of the enemy,” Califf told The Associated Press in a 2016 interview. “So we’ve got to adjust.”

Califf’s extensive work with the drug industry drew scrutiny during his Senate confirmation hearing, though he was ultimately confirmed by an overwhelming margin. Given the pressing need for a permanent commissioner, he is expected to again win bipartisan confirmation. He also has the backing of the powerful pharmaceutical and medical device lobbying groups in Washington.

Califf has worked as a consultant for several major pharmaceutical companies and sits on the board of two smaller biotech companies.

Federal ethics rules do not require government officials to sell all their investments, but they must recuse themselves from matters that could affect those investments. As part of the vetting process, FDA nominees typically disclose and sell stocks, funds and other investments that could pose a financial conflict of interest.

FDA watchers said Califf had several key advantages over other candidates vetted for the job, several of whom would have faced more scrutiny in the Senate.

“He knows how the FDA works, and he avoided making any outrageous decisions as commissioner,” said Diana Zuckerman of the non-profit National Center for Health Research. “Those are essential if the FDA is going to regain the public trust.”

His first tasks would include easing burnout and boosting morale among the FDA’s 18,000 employees. The agency’s medical reviewers have been straining for months under a crushing coronavirus pandemic workload, while the agency’s reputation for scientific independence has been battered by a string of public controversies.

Two congressional committees are investigating the agency’s June approval of the much-debated Alzheimer’s drug Aduhelm against the recommendation of its outside experts, three of whom resigned over the decision. Then in September, two top FDA vaccine regulators announced they would leave the agency after disagreeing with the Biden administration plan to make COVID-19 vaccines boosters widely available.

In recent weeks the FDA has authorized extra doses of all three COVID-19 vaccines for certain groups, though not as broadly as Biden originally proposed. Pfizer has recently applied to expand eligibility for its booster to all adults, a request the FDA is expected to grant.

The latest FDA troubles followed months of turmoil between the agency and the White House under President Donald Trump, who falsely accused the agency of deliberately slowing its review of COVID-19 vaccines to sway the presidential election.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, Top General short headlines, AP Online Headlines - Washington, AP Online Congress News, AP Health
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Biden picks former FDA chief Califf to again lead the agency
President Joe Biden is nominating former Food and Drug Administration commissioner Dr. Robert Califf to again lead the regulatory agency
10:17AM ( 6 minutes ago )
Disease center urges Germans to cancel or avoid big events
Germany’s disease control center is calling for people to cancel or avoid large events and to reduce their contacts as the country’s coronavirus infection rate hits the latest in a string of new highs
10:16AM ( 7 minutes ago )
Leona Maguire thrives in star pairing for 62 to lead LPGA
Leona Maguire must have felt she was back in the Solheim Cup
10:06AM ( 17 minutes ago )
Associated Press (AP)
What sub spat? Harris didn't discuss it with French leader
U.S. Vice President Kamala Harris says she didn’t discuss the secret submarine deal that sent U.S.-French relations to a historic low when she met this week with French President Emmanuel Macron
9:19AM ( 1 hour ago )
Blinken headed to Africa to address various crises
Secretary of State Antony Blinken will travel to Africa next week as the Biden administration intensifies diplomatic efforts to resolve crises in Ethiopia and Sudan and seeks to boost counterterrorism cooperation
8:09PM ( 14 hours ago )
Court temporarily delays release of Trump's Jan. 6 records
A federal appeals court has temporarily blocked the release of White House records sought by a U.S. House committee investigating the Jan. 6 insurrection, granting — for now — a request from former President Donald Trump
7:00PM ( 15 hours ago )
AP Online Headlines - Washington
Big Bird backlash: Vax lands even Muppet in political flap
In 1972, Big Bird lined up on `Sesame Street' to receive a measles vaccine as part of a campaign to get more youngsters inoculated against the disease
2:20PM ( 20 hours ago )
Democrats sell infrastructure bill, push for Biden backup
Congressional Democrats who are facing potentially tough reelection fights next year are crowing about long-neglected public works projects set to spring to life thanks to the new infrastructure package
9:50AM ( 1 day ago )
AP Online Congress News
All Czech students to be tested to curb surge in virus cases
The Czech government is requiring children to get tested for COVID-19 as part of efforts to curtail a recent steep rise in cases
6:23AM ( 4 hours ago )
Japan adding more hospital beds in plan for next virus surge
Japan’s preparations for the next coronavirus surge include adding thousands more hospital beds to avoid a situation like last summer when many COVID-19 patients were forced to stay home, even when they needed supplemental oxygen
4:40AM ( 5 hours ago )
German leader Merkel says people have duty to get vaccinated
German Chancellor Angela Merkel says people have a duty to get vaccinated against the coronavirus to protect others
8:09PM ( 14 hours ago )
AP Health
Disease center urges Germans to cancel or avoid big events
Germany’s disease control center is calling for people to cancel or avoid large events and to reduce their contacts as the country’s coronavirus infection rate hits the latest in a string of new highs
10:16AM ( 8 minutes ago )
Leona Maguire thrives in star pairing for 62 to lead LPGA
Leona Maguire must have felt she was back in the Solheim Cup
10:06AM ( 17 minutes ago )
The Latest: Kerry outlines US position on final climate deal
U.S. climate secretary John Kerry says his country is backing part of a draft U.N. climate deal that calls for phasing out use of “unabated” coal and ending at least some fossil fuel subsidies by governments
10:05AM ( 19 minutes ago )
Pacific leaders agree on vaccines but not on US hosting APEC
Pacific Rim leaders have agreed to do all they can to improve access to coronavirus vaccines and reduce carbon emissions, but failed to reach agreement on whether the U.S. should host talks in two years’ time
9:57AM ( 27 minutes ago )
Alaska Sen. Lisa Murkowski to run in 2022; Trump backs rival
Republican Sen. Lisa Murkowski of Alaska says she's running for reelection next year
9:57AM ( 27 minutes ago )